Showing Articles for
Cancer
Lawyers for Roundup Plaintiffs Push for Settlement
MedTruth Editors · September 28, 2022
Attorneys want Roundup litigation resolved, either through a global settlement or a return of the cases.
Legal DevelopmentsZantac Expert Testimony Hearings To Be Held
MedTruth Editors · September 27, 2022
These special hearings will determine which expert witnesses will be allowed to testify in the Zantac trials.
Legal DevelopmentsBayer Wins Multi-Plaintiff Roundup Cancer Trial
MedTruth Editors · September 23, 2022
The Missouri trial included three plaintiffs who have non-Hodgkin’s lymphoma, allegedly because of Roundup exposure.
Legal DevelopmentsGet our reporting in your inbox
Additional Breast Implant Cancers Discovered
MedTruth Editors · September 20, 2022
In addition to BIA-ALCL, a lymphoma associated with breast implants, numerous cancers have been detected in tissues surrounding breast implants.
NewsLawmakers Demand DOJ Update on J&J Talc Probe
MedTruth Editors · September 16, 2022
The investigation aims to determine if Johnson & Johnson misled the public about the risks of using its talcum-based products after claims that the asbestos-contaminated powder causes cancer.
Laws + CongressPro-Business Nonprofit Backs J&J Bankruptcy Proceeding
MedTruth Editors · September 6, 2022
A legal nonprofit submitted a document in support of Johnson & Johnson’s bankruptcy proceedings surrounding the company's talcum powder cancer cases.
Legal DevelopmentsFirst Zantac Trial Ends in Settlement
MedTruth Editors · August 31, 2022
Joseph Bayer agreed to drop his lawsuit, which was scheduled to be held in an Illinois state court, after reaching a settlement of more than $500,000 with generic makers of Zantac.
Legal DevelopmentsAllergan Compelled to Produce Documents in Breast Implant MDL
MedTruth Editors · August 25, 2022
Allergan must produce documents related to over 400 patients to inform the bellwether selection process. Plaintiffs claim Allergan breast implants caused them to develop cancer.
Legal DevelopmentsJ&J Announces Global Talc Phase Out
MedTruth Editors · August 24, 2022
Starting in 2023, J&J will no longer sell talcum-based baby powder products anywhere in the world. These products have been discontinued in the U.S. and Canada since 2020.
NewsNew Roundup Trial Underway in Monsanto’s Hometown
Guest Contributor · August 18, 2022
Three people who used Roundup and have since been diagnosed with different types of lymphoma are suing Monsanto. The trial takes place in St. Louis, the headquarters of Monsanto.
Legal DevelopmentsFirefighters File PFAS Class Action
MedTruth Editors · August 5, 2022
PFAS chemicals, which are resistant to breaking down naturally in the environment, may accumulate in human tissue and have been associated with various health complications.
NewsAppeals Court Reverses $120 Million Mesothelioma Decision Against J&J
MedTruth Editors · August 3, 2022
The court ruled that Olson’s legal team did not present expert testimony that established sufficient evidence that Olson’s exposure to talcum in J&J’s products caused her health to deteriorate.
Legal DevelopmentsSupreme Court Declines To Review $87M Pilliod Roundup Case
MedTruth Editors · July 8, 2022
The Supreme Court turned away Bayer’s appeal of Alva and Alberta Pilliod's Roundup cancer case.
Legal DevelopmentsZantac Bellwether Dates Set in CA
MedTruth Editors · July 6, 2022
The first four Zantac trials in California have been set for 2023. Zantac users claim that they were unknowingly exposed to unsafe levels of NDMA.
Legal DevelopmentsEPA Ordered To Reconsider Glyphosate Safety
MedTruth Editors · June 29, 2022
The EPA must reexamine its 2020 findings that glyphosate, the main active ingredient in Monsanto’s Roundup weedkiller products, is “not likely” to cause cancer.
Laws + CongressJudge Blocks Media Coverage of Roundup Cancer Trial
MedTruth Editors · June 27, 2022
The judge decided the media coverage might put pressure on the jury, resulting in jurors potentially dropping out.
Legal DevelopmentsFDA Announces New Breast Implant Study
MedTruth Editors · June 23, 2022
BIA-ALCL is a man-made cancer, a specific type of T-cell lymphoma, that is associated with textured breast implants.
NewsSupreme Court Urged To Let $25M Roundup Cancer Award Stand
MedTruth Editors · May 25, 2022
The U.S. Department of Justice has recommended that the lower court verdict be allowed to stand.
Legal DevelopmentsFormer Monsanto CEO Testifies in First Roundup Trial Outside California
MedTruth Editors · May 20, 2022
This is the first trial in which former CEO of Monsanto Hugh Grant, who ran the company for 15 years, will testify.
Legal DevelopmentsRoundup Judge Criticizes Proposed False Advertising Settlement
MedTruth Editors · April 27, 2022
The settlement would provide payments to consumers who purchased certain Roundup products and resolve a lawsuit claiming that Monsanto failed to warn users.
Legal DevelopmentsBayer Settles Dozens of Roundup Cancer Claims
MedTruth Editors · April 20, 2022
In March, Bayer announced that of approximately 138,000 cancer claims filed by individuals, 107,000 had been resolved or deemed ineligible.
Legal DevelopmentsJudge Grants Fast-Track Appeal of J&J’s Talc Bankruptcy
MedTruth Editors · April 13, 2022
Judge Kaplan allowed plaintiffs who have alleged that J&J’s asbestos-contaminated talc products caused them to develop cancer to appeal his ruling
Legal DevelopmentsAcrylamide Lawsuits Halted Over Inconclusive Cancer Claims
MedTruth Editors · March 31, 2022
The federal court ruled that there is not enough evidence proving that acrylamide, a substance that’s formed during the heating process of certain foods, causes cancer.
NewsBayer Brings Second Roundup Verdict Petition to Supreme Court
MedTruth Editors · March 30, 2022
The company behind Roundup weedkiller, which thousands claim caused their cancer, is petitioning the nation’s high court to review a Roundup case for the second time.
Legal DevelopmentsJ&J Tested Asbestos On Inmates, Unsealed Docs Reveal
MedTruth Editors · March 23, 2022
The company hired a doctor to test the effects of asbestos on the inmates’ skin against the effects of talc.
NewsChantix Carcinogen Class Action Dismissed
MedTruth Editors · March 16, 2022
The complaint accused Pfizer of misrepresenting the safety of the drug to consumers by failing to properly test Chantix despite warnings from regulators.
NewsBankruptcy Court Approves J&J Talc Case
MedTruth Editors · March 8, 2022
The judge is allowing Johnson & Johnson to move forward with the bankruptcy process for the company's new entity, LTL Management.
Legal DevelopmentsCA State Court Hears Zantac Lawsuits in October
MedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsJudge Declines To Decide Talc Committee’s Motions
MedTruth Editors · February 8, 2022
Judge Freda L. Wolfson has declined to decide issues arising from the bankruptcy of J&J’s subsidiary, LTL Management.
Legal DevelopmentsSanofi Wins Taxotere Trial Over Hair Loss Claims
MedTruth Editors · February 2, 2022
Over 12,000 individuals allege that the breast cancer drug Taxotere caused their permanent hair loss, and that manufacturer Sanofi was aware that this could be a side effect of the drug.
Legal DevelopmentsRoundup Attorneys May Face Malpractice Claims For Failing to Produce Experts
MedTruth Editors · January 28, 2022
Judge Chhabria’s order stated that plaintiffs must produce an expert to support their claim that Roundup caused their non-Hodgkin's lymphoma.
Legal DevelopmentsSupreme Court Asks Biden Admin To Weigh In on Roundup Appeal
MedTruth Editors · January 25, 2022
The U.S. Supreme Court asked the Solicitor General for the administration's views on the Roundup cancer trial that awarded plaintiff Edwin Hardeman $25 million.
Legal DevelopmentsBayer Settles Boy's Roundup Rare Cancer Claims
MedTruth Editors · January 19, 2022
A mother claims her son developed Burkitt’s lymphoma from years of Roundup exposure.
Legal DevelopmentsCancer Researchers Criticize Glyphosate Approval in the EU
MedTruth Editors · December 9, 2021
Europe’s leading cancer researchers are questioning the EU's decision to issue a positive safety review for glyphosate.
Research + FindingsTalc Advocates Reject J&J Settlement Talks
MedTruth Editors · November 29, 2021
Johnson & Johnson will most likely have to wait until at least 2022 before it can restart to negotiate a resolution.
Legal DevelopmentsJ&J Allegedly Delaying Talc Trial in Mississippi
MedTruth Editors · November 17, 2021
Mississippi's Attorney General urged the Supreme Court to reject J&J's petition to delay the state’s seven-year talcum powder lawsuit.
Legal DevelopmentsJ&J Wins Third Post-Pandemic Talc Powder Ovarian Cancer Trial
MedTruth Editors · October 22, 2021
This marks J&J’s third ovarian cancer talc trial win since cases were resumed after pandemic lockdowns.
Legal DevelopmentsBranded Zantac Makers Can’t Escape Class-Action, Judge Rules
MedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsJ&J Cleared in PA Talc Trial
MedTruth Editors · October 5, 2021
A jury acquitted Johnson & Johnson of civil liability for one woman’s ovarian cancer.
Legal DevelopmentsJudge Prevents Injunction Against J&J Asset Splitting
MedTruth Editors · September 30, 2021
The plaintiffs argue that this financial maneuver would unlawfully shield Johnson & Johnson from any liability the company may owe for its talcum powder’s connection to ovarian cancer.
Legal DevelopmentsDates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsJ&J Returns to Court In “Ground Zero” For Ovarian Cancer Lawsuits
MedTruth Editors · September 24, 2021
The first J&J talcum powder trial since before the pandemic has begun in Missouri over ovarian cancer claims.
Legal DevelopmentsNewly-Released Internal EPA Report Links Glyphosate to Cancer
MedTruth Editors · September 8, 2021
An internal EPA document from 2016 suggested that several studies reported elevated risks of non-Hodgkin's lymphoma associated with glyphosate exposure.
NewsJ&J Hit With $26.5 Million Talc Verdict
MedTruth Editors · September 2, 2021
Christina Prudencio's lawyer claimed her terminal mesothelioma was rooted in Johnson & Johnson ignoring decades of proof that their talcum products were unsafe.
Legal DevelopmentsJ&J Concealed Talc Risks To Preserve Brand Image, Philly Jury Told
MedTruth Editors · September 1, 2021
The plaintiff in a Philadelphia trial claimed J&J was aware that its baby powder was associated with cancer risk but withheld that information for decades in order to protect its brand image.
NewsSupreme Court Allows Johnson & Johnson's $2 Billion Baby Powder Cancer Verdict
MedTruth Editors · June 7, 2021
The Supreme Court has allowed a $2.1 billion baby powder cancer verdict against Johnson & Johnson to stand.
NewsJohnson and Johnson Talcum Powder Lawsuits: Recent Developments
Guest Contributor · January 29, 2021
An update on lawsuits claiming J&J's talcum powder causes ovarian cancer.
Legal DevelopmentsFibroid Removal Safety Recommendations Updated by FDA
Carah Wertheimer · January 7, 2021
The FDA has finalized safety recommendations for the use of power morcellators in surgeries to remove fibroids.
FDA Regulation$2.1 Billion Talcum Powder Cancer Verdict Stands, J&J Appealing to Supreme Court
James Parker · November 12, 2020
Johnson & Johnson intends to appeal a record $2.1 billion talc verdict after striking out in the Missouri Supreme Court.
Legal DevelopmentsNew Blood Test Detects Cancer Up to 4 Years Before Diagnosis
Carah Wertheimer · September 18, 2020
A cutting-edge blood test can detect five common cancers up to four years before most people even know they have the disease.
NewsNo Increased Risk of Most Cancers From Hair Dye, Study Says
Carah Wertheimer · September 14, 2020
A major study found no increased risk of most types of cancer in women who use permanent hair dye at home.
Research + FindingsCalifornia Attorneys Seek to Consolidate Zantac Lawsuits
James Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsHow to Navigate Statutes of Limitation in Talc-Cancer Claims
Lynne Higby · May 27, 2020
Questions about the statute of limitations for ovarian cancer wrongful death claims have been raised by the families of women who used Johnson & Johnson's talcum powder products.
Legal DevelopmentsJohnson & Johnson Discontinues Talcum Powder in the U.S. & Canada
Carah Wertheimer · May 19, 2020
J&J will withdraw its signature talcum powder from North American markets, insisting the product is safe despite nearly 20,000 lawsuits alleging that asbestos-contaminated powder caused cancer.
NewsCoronavirus Delays Chemotherapy for Cancer Patients
Benjamin Duong · April 16, 2020
Patients with cancer, already vulnerable with many dependent on regular treatment appointments, are facing delayed chemotherapy, surgeries and even outright cancellations.
NewsZantac and Ranitidine Products Removed from U.S. Market
Ashley Lombardo · April 1, 2020
On April 1, the U.S. Food and Drug Administration requested immediate removal of Zantac products from the U.S. market, including all prescription and over-the-counter medications containing ranitidine.
NewsJohnson & Johnson Talc Appeal Unhindered by COVID-19 Shutdown
James Parker · March 30, 2020
A Missouri appellate court set an April 24 date for Johnson & Johnson’s $4.69 billion talc appeal, despite the Missouri Supreme Court’s cancellation of all April arguments to reduce COVID-19 exposure.
Legal DevelopmentsChemical Hair Dyes and Straighteners May Increase Breast Cancer Risk
Benjamin Duong · March 2, 2020
Use of hair dyes and chemical hair straighteners may be associated with an increased risk of breast cancer, with black women being at an increased risk compared to white women.
Research + FindingsMT Weekly: J&J Asbestos Settlement, EPA to Regulate PFAS
Carah Wertheimer · February 25, 2020
This week, MedTruth provides updates on the latest baby powder settlement, the EPA's new regulations on PFAS, plus a study on the impacts of chemical exposure during pregnancy.
NewsiPap: The Emerging Future of Cervical Cancer Screening Technology
Tess Francke · January 21, 2020
A new, at-home cervical cancer screening test may just revolutionize early detection, especially in international markets that lack the infrastructure to provide easy access to doctors and regular pap smear tests.
Women's HealthExposure to Heat During Storage Causes Zantac Contamination
Benjamin Duong · January 14, 2020
Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.
NewsStudy Exploring Talc-Cancer Link Underrepresents Populations of Color
Benjamin Duong · January 13, 2020
A recent baby powder study found an insignificant link between the substance and ovarian cancer, but the study has limitations, including underrepresenting populations of color.
Research + FindingsMore Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall
James Parker · January 13, 2020
Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.
FDA RegulationFDA Schedules Public Meeting to Assess Testing for Asbestos in Talc
James Parker · January 13, 2020
The public meeting may be crucial to qualifying expert witnesses for thousands of plaintiffs involved in national talcum powder cases.
FDA RegulationFDA Metformin Probe Investigates Potential NDMA Hazard
James Parker · January 8, 2020
An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.
FDA RegulationLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsBreast Cancer Awareness Month 2019 Explores All Reconstruction Options
S. Nicole Lane · October 16, 2019
This October, in honor of Breast Cancer Awareness Month, MedTruth recognizes the AiRS Foundation, which supports cancer survivors by providing information and financial aid to those considering reconstruction. It's important to note that reconstruction isn't the only option. Some women are taking social media by storm, advising women to "choose flat."
Health FeaturesNew Patient Reporting Technology Empowers Cancer Patients, Offering Remote Care
Tess Francke · October 8, 2019
Recent studies have found that rural cancer patients face challenges in accessing quality care over their metropolitan counterparts, which may impact life expectancy. Noona, a new system designed to provide cancer patients care and symptom assessment from the comfort of their own home, may just change that.
MedTechWorried About Breast Cancer? Science Says Eat More Chicken, Less Red Meat
Carah Wertheimer · October 8, 2019
Research shows that women who consumed poultry rather than red meat had a significantly lower risk of breast cancer.
Research + FindingsAdaptive Radiotherapy: Cancer Treatment May Be Safer, More Accessible
Benjamin Duong · August 21, 2019
Adaptive radiotherapy is a form of personalized radiation therapy for cancer treatment. Although still in its early stages, clinicians hope that with further development to imaging methods, this form of cancer treatment will be a safer option to target tumors while minimizing tissue damage.
Research + FindingsIn the Lab: Ovarian Cancer Cells Show Mutation from Talc Exposure
Tess Francke · June 24, 2019
The link between talc powder and ovarian cancer has been warned about for years. Now, a recent study identifying evidence of cell mutation shows the way talc powder promotes the generation of ovarian cancer cells. This is the first study to confirm the cellular effect of talc.
Research + FindingsResearchers Develop New Blood Test to Detect Cancer in 10 Minutes
Tess Francke · April 11, 2019
It's a quest to detect multiple types of cancer in its early stages with the simple blood test that would take under 10 minutes to report results. Researchers say it will be at least five years before there is sufficient data to show whether it can work.
NewsWhy We Still Aren’t Educated Enough on Ovarian Cancer
S. Nicole Lane · November 14, 2018
A recent report found that many women don’t know that much about ovarian cancer whatsoever.
Women's HealthPreliminary Study Finds Ovarian Cancer May Start in Fallopian Tubes
Ashley Lombardo · October 25, 2017
An ovarian cancer study indicates the disease may originate in the fallopian tubes. Scientists used genome sequencing to examine DNA errors.
Research + Findings